Status:
COMPLETED
Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
To compare the effects of the combination of ETN and MTX to MTX alone on radiographic change and clinical disease activity in subjects with early RA over 12 months.
Eligibility Criteria
Inclusion
- Satisfies the 1987 ACR Revised Criteria for Rheumatoid Arthritis
- Has RA greater than or equal to 3 months and less than or equal to 2 years
Exclusion
- Received any previous treatment with MTX
- Received any previous treatment with ETN or other tumour necrosis factor antagonist
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
542 Patients enrolled
Trial Details
Trial ID
NCT00195494
Start Date
November 1 2004
End Date
March 1 2008
Last Update
September 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver, Colorado, United States, 80230